Evidence map›Paper›PMID 34789810›Full record

ArticleScientific reports2021

Exemplifying the next generation of antibiotic susceptibility intensifiers of phytochemicals by LasR-mediated quorum sensing inhibition.

Arpit Shukla, Gaurav Shukla, Paritosh Parmar, Baldev Patel, Dweipayan Goswami, Meenu Saraf

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Multidrug-resistantVirulence · 2025
    Review
  4. Article
  5. Article
  6. Theophylline as a quorum sensing and biofilm inhibitor in Pseudomonas aeruginosa and Chromobacterium violaceum.International microbiology : the official journal of the Spanish Society for Microbiology · 2024
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. ModifiedFrontiers in molecular biosciences · 2023
    Article
  13. Bioinformatics and biology insights · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Inhibition of Quorum-Sensing Regulator fromMolecules (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Arpit ShuklaDepartment of Microbiology & Biotechnology, University School of Sciences, Gujarat University, Ahmedabad, Gujarat, 380009, India.ORCID 0000-0003-3099-0036
Gaurav ShuklaPandit Deendayal Energy University, Raysan, Gandhinagar, Gujarat, 382426, India.ORCID 0000-0002-1704-4611
Paritosh ParmarDepartment of Microbiology & Biotechnology, University School of Sciences, Gujarat University, Ahmedabad, Gujarat, 380009, India.ORCID 0000-0001-6463-8124
Baldev PatelDepartment of Microbiology & Biotechnology, University School of Sciences, Gujarat University, Ahmedabad, Gujarat, 380009, India.
Dweipayan GoswamiDepartment of Microbiology & Biotechnology, University School of Sciences, Gujarat University, Ahmedabad, Gujarat, 380009, India. dweipayan.goswami@gujaratuniversity.ac.in.ORCID 0000-0003-0165-0294
Meenu SarafDepartment of Microbiology & Biotechnology, University School of Sciences, Gujarat University, Ahmedabad, Gujarat, 380009, India. msaraf@gujaratuniversity.ac.in.ORCID 0000-0003-4964-9452
Gujarat University · INPandit Deendayal Energy University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There persists a constant threat from multidrug resistance being acquired by all human pathogens that challenges the well-being of humans. This phenomenon is predominantly led by Pseudomonas aeruginosa which is already resistant to the current generations of antibiotic by altering its metabolic pathways to survive. Specifically for this microbe the phenomenon of quorum sensing (QS) plays a crucial role in acquiring virulence and pathogenicity. QS is simply the cross talk between the bacterial community driven by signals that bind to receptors, enabling the entire bacterial microcosm to function as a single unit which has led to control P. aeruginosa cumbersome even in presence of antibiotics. Inhibition of QS can, therefore, be of a significant importance to curb such virulent and pathogenic strains of P. aeruginosa. Natural compounds are well known for their antimicrobial properties, of which, information on their mode of action is scarce. There can be many antimicrobial phytochemicals that act by hindering QS-pathways. The rationale of the current study is to identify such natural compounds that can inhibit QS in P. aeruginosa driven by LasR, PhzR, and RhlR dependent pathways. To achieve this rationale, in silico studies were first performed to identify such natural compounds which were then validated by in vitro experiments. Gingerol and Curcumin were identified as QS-antagonists (QSA) which could further suppress the production of biofilm, EPS, pyocyanin, and rhamnolipid along with improving the susceptibility to antibiotics.

Indexed as

Anti-Bacterial AgentsBacterial ProteinsBiofilmsCatecholsCurcuminFatty AlcoholsGlycolipidsMicrobial Sensitivity TestsMolecular Dynamics SimulationPhytochemicalsPseudomonas aeruginosaPseudomonas InfectionsPyocyanineQuorum SensingSignal TransductionTrans-ActivatorsAnti-Bacterial AgentsBacterial ProteinsCatecholsCurcuminFatty AlcoholsgingerolGlycolipidsLasR protein, Pseudomonas aeruginosaPhytochemicalsPhzR protein, PseudomonasPyocyaninerhamnolipidRhlR protein, Pseudomonas aeruginosaTrans-Activators

Identifiers

PMID34789810
PMCPMC8599845
OpenAlexW3214318508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.